ThermoGenesis Holdings, Inc. (THMO) Stock in Decline after a Massive Monday, Here’s Why
ThermoGenesis Holdings, Inc. (THMO), a company involved in the development of automated technologies for cell-based therapies, soared 19.48% in Monday’s regular trading session and closed the day at $0.76. In the premarket session, THMO stock has slid 6.81%, owing to the profit-taking factor, and as